Skip to main content
. 2014 Mar 21;86(9):4521–4527. doi: 10.1021/ac500466x

Figure 2.

Figure 2

(A) Silencing of STIP1 in TOV-21G cells. The cells were tested for TOV6 binding after 72 h of siRNA treatment. (B) Absence of PTK7 silencing with STIP1 siRNA treatment in TOV-21G cells. The cells were tested for Sgc8 binding after 72 h of siRNA treatment. (C) Silencing of STIP1 in A172 cells. The cells were tested for TOV6 binding after 72 h of siRNA treatment. (D) Absence of PTK7 silencing with STIP1 siRNA treatment in A172 cells. The cells were tested for Sgc8 binding after 72 h of siRNA treatment. Key: red, A172 cells incubated with streptavidin–Alexa 488 only; green, library-incubated cells; black, scrambled siRNA-treated cells; dark blue, STIP1 siRNA 5; orange, STIP1 siRNA 6; light blue, STIP1 siRNA 10; magenta, STIP1 siRNA 11.